DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2004/0058321 A1 Brunkow Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2004/0058321 A1 Brunkow Et Al US 200400.58321A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0058321 A1 BrunkOW et al. (43) Pub. Date: Mar. 25, 2004 (54) COMPOSITIONS AND METHODS FOR Related U.S. Application Data INCREASING BONE MINERALIZATION (63) Continuation of application No. 09/449,218, filed on (75) Inventors: Mary E. Brunkow, Seattle, WA (US); Nov. 24, 1999, now Pat. No. 6,395,511. David J. Galas, Claremont, CA (US); Brian Kovacevich, Renton, WA (US); (60) Provisional application No. 60/110,283, filed on Nov. John T. Mulligan, Seattle, WA (US); 27, 1998. Bryan Paeper, Seattle, WA (US); Jeffrey Van Ness, Claremont, CA (US); Publication Classification David G. Winkler, Seattle, WA (US) (51) Int. Cl. ............................ C12O 1/68; CO7H 21/04; Correspondence Address: A61K 39/395; C12P 21/02; SEED INTELLECTUAL PROPERTY LAW C12N 5/06; CO7K 16/22 GROUP PLLC (52) U.S. Cl. ......................... 435/6; 435/69.1; 435/320.1; 701 FIFTHAVE 435/325; 530/388.25; 424/145.1; SUTE 6300 536/23.5 SEATTLE, WA 98104-7092 (US) (57) ABSTRACT (73) Assignee: Darwin Discovery Ltd., Slough (GB) A novel class or family of TGF-B binding proteins is (21) Appl. No.: 10/095,248 disclosed. Also disclosed are assays for Selecting molecules for increasing bone mineralization and methods for utilizing (22) Filed: Mar. 7, 2002 Such molecules. Patent Application Publication Mar. 25, 2004 Sheet 1 of 6 US 2004/0058321 A1 Common Cysteine Backbone 1. 50 human-gremlin.pro human-Cerberus pro MHLLLFOLLY LLPLGKTTRH ODGRONOSSL SPYLLPRNOR ELPTGNHEEA human-dan pro re-asawwara reserwrwarrara's swarara-as-a-Wiswe sawsWawswaas awaawawa-a-a-ay human-beer pro 51 100 human-gremlin.pro MSRTAYTVGALLLLLGTLLPA AEGKKKGSOG human-CerberuS. pro EEKPDLFVAY PHLVAT.SPAGEGOROREKMLSRFGRFWKK PEREMHPSRD human-dan-pro human-beer pro M M M MMOLPLA LCLYCLLVHT 101 150 human-gremlin.pro AI.PPPDKAQ HNDSEQTOSP OQPGSRNRGR GOGRGTAMPG EEYLESSQEA human-CerberuS. pro SDSEPFPPGT OSLIOPIDG MKMEKSPLRE EAKKFWHHFM FRKTPASQGV human-dan-pro MRVLVGAYL PAMLAAPPP human-beer.pro AFRYVEGOGW QAFKNDATEI IPELGEYPEP PPELENNKTM NRAENGGRPP 151 Y 200 human-gremlin.pro HVTERKYLK RDWCKTOPLK GTIHEEGCNS RIINRF.CY GOCNSFYIPR human-CerberUS. pro ILPIKSHEVH WETCRTYPFS QTITHEGCEK VVVONNLCF GKCGSVHFP. human-dan.pro INKLALFPDK SAWCEAKNIT QIVGHSGCEA KSIONRACL GOCFSYSVPN human-beer.pro HHPFETKDVS EYSCRELHFTRYVTDGPCRS AKPVTELVCS GOCGPARLLP 201 250 human-gremlin.pro HIRKEEGSFQ SCSF.CKP KKF TMMVT NCPELOPPTK K.KRVTRYKQ human-CerberuS. pro GAAQHSHT SCSH. CLP AKFTIMHLPL NCTELSSVIK V.VMLVEE human-dan-pro TFPOSTESLV HCDS. CMP AOSMWEIVTL ECPGHEEVPR YDKLVEKILH human-beer pro NAIGRGKWWR PSGPDFRCIP DRYRAORVOLLCPGGEAPRA RKVRLYAS. s 300 human-gremlin.pro CRC, ISIDLD Aawawawawa.AMAa human-Cerberus. pro COCKYKTEHE DGHILHAGSO DSFIPGVSA- ~~~~~~~~~~~ human-dan-pro CSCOACGKEP SHEGLSYYYO GEDGPGSOPG THPHPHPHPHPGGOTPEPED human-beer pro CKCKRLTRFH NOSELKDFGT EAARPOKGRK PRPRARSAKA NOAELENAY 301 314 human-gremlin, pro human-CerberuS. pro Awarwaw-w human-dan, pro PPGAPHTEEE GAED human-beer, pro ww.waw Fig. 1 Patent Application Publication Mar. 25, 2004 Sheet 2 of 6 US 2004/0058321 A1 Human Beer Gene Expression by RT-PCR BEER beta-actin ig. 2 Patent Application Publication Mar. 25, 2004 Sheet 3 of 6 US 2004/0058321 A1 Patent Application Publication Mar. 25, 2004 Sheet 4 of 6 US 2004/0058321 A1 Antibody Selectivity Anti Anti Anti Beer Don Gremlin Co BEER Protein S3 3se seS S3 seS s (75 ng/lane) Fig. 4A 50 kD 34 kD 28 kD 20 kD Anti Anti Anti Gremlin Beer Dan O Gremlin Protein S3 3s S S S S3 (75 ng/lane) : * : * : : 34 kD Fig.f 4B 28 kD 20 kD Anti Anti Anti Don Beer Gremlion . S s S 8 S 8 Dan Protein 3 S S 3 Se 3 (75 ng/lane) 54 kD 28 kD 20 kD Patent Application Publication Mar. 25, 2004 Sheet 5 of 6 US 2004/0058321 A1 07-dW80+-+ -1998++---•• –snuºqu30-++…-, : s g: ?ae?**¿ 3:is . Patent Application Publication Mar. 25, 2004 Sheet 6 of 6 US 2004/0058321 A1 BMP-5/Beer Dissociation Constant Characterization 75 15 7.5 15 50 60 120 nM. BMP-5 i. *Anti-FLAG immunoprecipitation Anti-BMP-5 Western blot lonic Disruption of BMP-5/Beer Binding NaCI(mlM) 500 150 150 lo Beer - A. BMP-5 *Anti-FLAG immunoprecipitation Anti-BMP-5 Western blot Fig. 6 US 2004/0058321 A1 Mar. 25, 2004 COMPOSITIONS AND METHODS FOR patient pool in the United States). The increased fragility and INCREASING BONE MINERALIZATION Susceptibility to fracture of skeletal bone in the aged is aggravated by the greater risk of accidental falls in this CROSS-REFERENCE TO RELATED population. More than 1.5 million osteoporosis-related bone APPLICATIONS fractures are reported in the United States each year. Frac tured hips, wrists, and vertebrae are among the most com 0001. This application claims priority from U.S. Provi mon injuries associated with Osteoporosis. Hip fractures in sional Application No. 60/110,283 filed Nov. 27, 1998, particular are extremely uncomfortable and expensive for which application is incorporated by reference in its entirety. the patient, and for women correlate with high rates of TECHNICAL FIELD mortality and morbidity. 0002 The present invention relates generally to pharma 0006 Although osteoporosis has been defined as an ceutical products and methods and, more specifically, to increase in the risk of fracture due to decreased bone mass, methods and compositions Suitable for increasing the min none of the presently available treatments for skeletal dis eral content of bone. Such compositions and methods may orders can Substantially increase the bone density of adults. be utilized to treat a wide variety of conditions, including for There is a Strong perception among all physicians that drugs example, osteopenia, Osteoporosis, fractures and other dis are needed which could increase bone density in adults, orders in which low bone mineral density are a hallmark of particularly in the bones of the wrist, Spinal column and hip the disease. that are at risk in Osteopenia and osteoporosis. 0007 Current strategies for the prevention of osteoporo BACKGROUND OF THE INVENTION sis may offer Some benefit to individuals but cannot ensure resolution of the disease. These Strategies include moderat 0003. Two or three distinct phases of changes to bone ing physical activity (particularly in weight-bearing activi mass occur over the life of an individual (see Riggs, West J. ties) with the onset of advanced age, including adequate Med. 154:63-77, 1991). The first phase occurs in both men calcium in the diet, and avoiding consumption of products and women, and proceeds to attainment of a peak bone mass. containing alcohol or tobacco. For patients presenting with This first phase is achieved through linear growth of the clinical osteopenia or Osteoporosis, all current therapeutic endochondral growth plates, and radial growth due to a rate drugs and Strategies are directed to reducing further loSS of of perioSteal apposition. The Second phase begins around bone mass by inhibiting the process of bone absorption, a age 30 for trabecular bone (flat bones such as the vertebrae natural component of the bone remodeling process that and pelvis) and about age 40 for cortical bone (e.g., long occurs constitutively. bones found in the limbs) and continues to old age. This phase is characterized by Slow bone loSS, and occurs in both 0008 For example, estrogen is now being prescribed to men and women. In Women, a third phase of bone loSS also retard bone loSS. There is, however, Some controversy over occurs, most likely due to postmenopausal estrogen defi whether there is any long term benefit to patients and ciencies. During this phase alone, women may lose an whether there is any effect at all on patients over 75 years additional 10% of bone mass from the cortical bone and 25% old. Moreover, use of estrogen is believed to increase the from the trabecular compartment (see Riggs, Supra). risk of breast and endometrial cancer. 0004 Loss of bone mineral content can be caused by a 0009 High doses of dietary calcium, with or without wide variety of conditions, and may result in Significant Vitamin D has also been Suggested for postmenopausal medical problems. For example, Osteoporosis is a debilitat Women. However, high doses of calcium can often have ing disease in humans characterized by marked decreases in unpleasant gastrointestinal Side effects, and Serum and uri skeletal bone mass and mineral density, Structural deterio nary calcium levels must be continuously monitored (see ration of bone including degradation of bone microarchitec Khosla and Rigss, Mayo Clin. Proc. 70:978-982, 1995). ture and corresponding increases in bone fragility and SuS 0010. Other therapeutics which have been suggested ceptibility to fracture in afflicted individuals. Osteoporosis include calcitonin, bisphosphonates, anabolic Steroids and in humans is preceded by clinical osteopenia (bone mineral Sodium fluoride. Such therapeutics however, have undesir density that is greater than one Standard deviation but leSS able side effects (e.g., calcitonin and Steroids may cause than 2.5 standard deviations below the mean value for young nausea and provoke an immune reaction, bisphosphonates adult bone), a condition found in approximately 25 million and Sodium fluoride may inhibit repair of fractures, even people in the United States. Another 7-8 million patients in though bone density increases modestly) that may prevent the United States have been diagnosed with clinical their usage (see Khosla and RigSS, Supra). osteoporosis (defined as bone mineral content greater than 2.5 Standard deviations below that of mature young adult 0011 No currently practiced therapeutic strategy bone). Osteoporosis is one of the most expensive diseases involves a drug that Stimulates or enhances the growth of for the health care System, coSting tens of billions of dollars new bone mass. The present invention provides composi annually in the United States. In addition to health care tions and methods which can be utilized to increase bone related costs, long-term residential care and lost working mineralization, and thus may be utilized to treat a wide days add to the financial and Social costs of this disease.
Load more

Recommended publications
  • RANDY SCHEKMAN Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, USA
    GENES AND PROTEINS THAT CONTROL THE SECRETORY PATHWAY Nobel Lecture, 7 December 2013 by RANDY SCHEKMAN Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, USA. Introduction George Palade shared the 1974 Nobel Prize with Albert Claude and Christian de Duve for their pioneering work in the characterization of organelles interrelated by the process of secretion in mammalian cells and tissues. These three scholars established the modern field of cell biology and the tools of cell fractionation and thin section transmission electron microscopy. It was Palade’s genius in particular that revealed the organization of the secretory pathway. He discovered the ribosome and showed that it was poised on the surface of the endoplasmic reticulum (ER) where it engaged in the vectorial translocation of newly synthesized secretory polypeptides (1). And in a most elegant and technically challenging investigation, his group employed radioactive amino acids in a pulse-chase regimen to show by autoradiograpic exposure of thin sections on a photographic emulsion that secretory proteins progress in sequence from the ER through the Golgi apparatus into secretory granules, which then discharge their cargo by membrane fusion at the cell surface (1). He documented the role of vesicles as carriers of cargo between compartments and he formulated the hypothesis that membranes template their own production rather than form by a process of de novo biogenesis (1). As a university student I was ignorant of the important developments in cell biology; however, I learned of Palade’s work during my first year of graduate school in the Stanford biochemistry department.
    [Show full text]
  • Fidelity of Human Immunodeficiency Viruses Type 1 and Type 2 Reverse Transcriptases in DNA Synthesis Reactions Using DNA and RNA Templates
    UNIVERSIDAD AUTÓNOMA DE MADRID Programa de Doctorado en Biociencias Moleculares Fidelity of Human Immunodeficiency Viruses Type 1 and Type 2 Reverse Transcriptases in DNA Synthesis Reactions using DNA and RNA Templates Alba Sebastián Martín Madrid, noviembre, 2018 Universidad Autónoma de Madrid Facultad de Ciencias Departamento de Biología Molecular Programa de doctorado en Biociencias Moleculares Fidelity of Human Immunodeficiency Viruses Type 1 and Type 2 Reverse Transcriptases in DNA Synthesis Reactions using DNA and RNA Templates Memoria presentada por Alba Sebastián Martín, graduada en Biología, para optar al título de doctora en Biociencias Moleculares por la Universidad Autónoma de Madrid Director de la Tesis: Dr. Luis Menéndez Arias Este trabajo ha sido realizado en el Centro de Biología Molecular ‘Severo Ochoa’ (UAM-CSIC), con el apoyo de una beca de Formación de Profesorado Universitario, financiada por el Ministerio de Educación, Cultura y Deporte (FPU13/00693). Abbreviations 3TC 2’ 3’-dideoxy-3’-thiacytidine AIDS Acquired immunodeficiency syndrome AMV Avian myeloblastosis virus APOBEC Apolipoprotein B mRNA editing enzyme ATP Adenosine 5’ triphosphate AZT 3’-azido-2’, 3’-dideoxythymidine (zidovudine) AZT-MP 3´-azido-2´, 3´-dideoxythymidine monophosphate AZTppppA 3´azido-3´-deoxythymidine-(5´)-tetraphospho-(5´)-adenosine bp Base pair BSA Bovine serum albumin CA Capsid protein cDNA Complementary DNA Cir-Seq Circular sequencing CypA Cyclophilin A dATP 2’-deoxyadenoside 5’-triphosphate dCTP 2’-deoxycytidine 5’-triphosphate ddC
    [Show full text]
  • Table of Contents
    Copyright by William Paul Robins 2008 The Dissertation Committee for William Paul Robins certifies that this is the approved version of the following dissertation ANTITERMINATION IS OPERATIVE IN BACTERIOPHAGE T7 AND IS LARGELY DEPENDENT ON ONE PROMOTER Committee: ____________________________________ Ian J. Molineux , Supervisor ____________________________________ Whitney Yin ____________________________________ Tanya Paull ____________________________________ Richard Meyer ____________________________________ Charles Earhart ANTITERMINATION IS OPERATIVE IN BACTERIOPHAGE T7 AND IS LARGELY DEPENDENT ON ONE PROMOTER by William Paul Robins, B.S. DISSERTATION Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY The University of Texas at Austin August 2008 DEDICATION This Dissertation is dedicated to the memory of my grandfather, Paul Rogers. His profound love of nature influenced my desire to study Science. ACKNOWLEDGEMENTS I would like to thank my supervisor Ian Molineux for his support and encouragement. His rigorous, thorough, and enthusiastic approach to science has been a valuable experience. I expect his mentoring will be a very positive influence on my future endeavors. I am also grateful to Pricilla Kemp for additional help and assistance in my work. I would also like to acknowledge Dhruti Savalia for investigating and analyzing my promoter mutations using abortive transcription assays and primer extension experiments. Her biochemical approach on T7 gene 2 was a very useful complement to the phage genetics in our lab. Finally, I need to thank my family; especially my wife Hannah Robins, my son Jefferson Pinkus and my parents Sam Robins and Gail Levansellar. v ANTITERMINATION IS OPERATIVE IN BACTERIOPHAGE T7 AND IS LARGELY DEPENDENT ON ONE PROMOTER William Paul Robins, Ph.D.
    [Show full text]
  • (Λ) Rex Phenotype
    Isolation and Characterization of Host mutations that Supress the Bacteriophage Lambda (λ) Rex Phenotype by Hibah Alattas A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Master of Science in Pharmacy Waterloo, Ontario, Canada, 2015 ©Hibah Alattas 2015 Author’s Declaration I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract The Bacteriophage lambda (λ) T4rII exclusion (Rex) phenotype is defined as the inability of T4rII mutant bacteriophage to form plaques on a lawn of E. coli lysogenized by bacteriophage λ. More than six decades have passed following the discovery of Rex by Seymour Benzer in 1955, yet the mechanism behind this elusive exclusion system remains a mystery. The Rex system is encoded by two genes of λ (rexA, and rexB), the expression of which, is primarily regulated by the repressor gene cI from the PM promoter. The onset of the Rex phenotype, somehow triggered by T4rII infection of a Rex+ lysogen, results in rapid membrane depolarization and a harsh cellular environment that in many ways resembles the stationary phase in metabolism and morphology. In addition, the disruption of the RexA:RexB balance, particularly the over expression of rexA to rexB, can lead to same manifestations without infection, indicating that stoichiometry of RexA:RexB is important. Despite some cell killing, infected lysogens can to some extent recover from Rex activation.
    [Show full text]
  • Escherichia Coli
    Escherichia coli “E. coli” redirects here. For the protozoan commensal, 1 Biology and biochemistry see Entamoeba coli. This article is about Escherichia coli as a species. For E. coli in medicine, see Pathogenic Escherichia coli. For E. coli in molecular biology, see Escherichia coli (molecular biology). Escherichia coli (/ˌɛʃᵻˈrɪkiə ˈkoʊlaɪ/;[1] also known as E. coli) is a Gram-negative, facultatively anaerobic, rod- shaped bacterium of the genus Escherichia that is com- monly found in the lower intestine of warm-blooded or- ganisms (endotherms).[2] Most E. coli strains are harm- less, but some serotypes can cause serious food poisoning in their hosts, and are occasionally responsible for product recalls due to food contamination.[3][4] The harmless strains are part of the normal flora of the gut, and can [5] benefit their hosts by producing vitamin K2, and pre- venting colonization of the intestine with pathogenic bac- teria.[6][7] E. coli is expelled into the environment within Model of successive binary fission in E. coli fecal matter. The bacterium grows massively in fresh fe- cal matter under aerobic conditions for 3 days, but its numbers decline slowly afterwards.[8] E. coli and other facultative anaerobes constitute about 0.1% of gut flora,[9] and fecal–oral transmission is the major route through which pathogenic strains of the bac- terium cause disease. Cells are able to survive outside the body for a limited amount of time, which makes them potential indicator organisms to test environmental sam- ples for fecal contamination.[10][11] A growing body of re- search, though, has examined environmentally persistent E.
    [Show full text]
  • Phage Lambda P Protein: Trans-Activation, Inhibition Phenotypes and Their Suppression
    Viruses 2013, 5, 619-653; doi:10.3390/v5020619 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Article Phage Lambda P Protein: Trans-Activation, Inhibition Phenotypes and their Suppression Sidney Hayes *, Craig Erker, Monique A. Horbay, Kristen Marciniuk, Wen Wang and Connie Hayes Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, S7N 5E5 Canada; E-Mails: [email protected] (S.H.); [email protected] (C.E.); [email protected] (M.A.H.); [email protected] (K.M.); [email protected] (W.W.); [email protected] (C.H.) * Author to whom correspondence should be addressed; [email protected]; Tel.: +1-306-966-4307; Fax: +1-306-966-4298. Received: 4 December 2012; in revised form: 21 January 2013 / Accepted: 29 January 2013 / Published: 6 February 2013 Abstract: The initiation of bacteriophage λ replication depends upon interactions between the oriλ DNA site, phage proteins O and P, and E. coli host replication proteins. P exhibits a high affinity for DnaB, the major replicative helicase for unwinding double stranded DNA. The concept of P-lethality relates to the hypothesis that P can sequester DnaB and in turn prevent cellular replication initiation from oriC. Alternatively, it was suggested that P-lethality does not involve an interaction between P and DnaB, but is targeted to DnaA. P-lethality is assessed by examining host cells for transformation by ColE1-type plasmids that can express P, and the absence of transformants is attributed to a lethal effect of P expression. The plasmid we employed enabled conditional expression of P, where under permissive conditions, cells were efficiently transformed.
    [Show full text]
  • Structure and Function of the Bacterial Genome
    k Structure and Function of the Bacterial Genome k k k k Structure and Function of the Bacterial Genome Charles J. Dorman Department of Microbiology, Moyne Institute of Preventive Medicine, Trinity College Dublin, Dublin 2, Ireland k k k k This edition first published 2020 © 2020 John Wiley & Sons, Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions. The right of Charles J. Dorman to be identified as the author of this work has been asserted in accordance with law. Registered Office John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA Editorial Office Boschstr. 12, 69469 Weinheim, Germany For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com. Wiley also publishes its books in a variety of electronic formats and by print-on-demand. Some content that appears in standard print versions of this book may not be available in other formats. Limit of Liability/Disclaimer of Warranty While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose.
    [Show full text]
  • The Rex System of Bacteriophage K: Tolerance and Altruistic Cell Death
    Downloaded from genesdev.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press The Rex system of bacteriophage k: tolerance and altruistic cell death David H. Parma, Marlene Snyder/ Sergey Sobolevski, Myra Nawroz, Edward Brody/ and Larry Gold Department of Molecular, Cellular, and Development Biology, University of Colorado, Boulder, Colorado 80309-0347 USA; ^Department of Biology, Mount St. Vincent University, Halifax, Nova Scotia, Canada B3M 2J6; ^Centre National de la Recherche Scientifique, Centre de Genetique Moleculaire, 91190 Gif-sur-Yvette, France The rexA and rexB genes of bacteriophage A. encode a two-component system that aborts lytic growth of bacterial viruses. Rex exclusion is characterized by termination of macromolecular synthesis, loss of active transport, the hydrolysis of ATP, and cell death. By analogy to colicins El and K, these results can be explained by depolarization of the cytoplasmic membrane. We have fractionated cells to determine the intracellular location of the RexB protein and made RexB—alkaline phosphatase fusions to analyze its membrane topology. The RexB protein appears to be a polytopic transmembrane protein. We suggest that RexB proteins form ion channels that, in response to lytic growth of bacteriophages, depolarize the cytoplasmic membrane. The Rex system requires a mechanism to prevent X itself from being excluded during lytic growth. We have determined that overexpression of RexB in A. lysogens prevents the exclusion of both T4 rll mutants and X ren mutants. We suspect that overexpression of RexB is the basis for preventing self-exclusion following the induction of a \ lysogen and that RexB overexpression is accomplished through transcriptional regulation.
    [Show full text]
  • Structural Basis of Transcription Inhibition by the DNA Mimic Protein Ocr
    bioRxiv preprint doi: https://doi.org/10.1101/822460; this version posted October 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Structural basis of transcription inhibition by the DNA mimic protein Ocr 2 of bacteriophage T7 3 4 Fuzhou Ye1, Ioly Kotta-Loizou2, Milija Jovanovic2, Xiaojiao Liu1,3, David T. F. Dryden4, 5 Martin Buck2 and Xiaodong Zhang1* 6 7 1Section of structural biology, Department of Infectious Diseases, Faculty of Medicine, 8 2Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, 9 London SW7 2AZ, UK. 10 3College of Food Science and Engineering, Northwest A&F University, Xinong Road 11 No. 22, Yangling, Shanxi Province, China. 12 4’Department of Biosciences, Durham University, Stockton Road, Durham DH1 3LE, 13 UK. 14 15 *Correspondence should be addressed to [email protected] 16 17 18 Abstract 19 Bacteriophage T7 infects Escherichia coli and evades the host defence system. The 20 Ocr protein of T7 was shown to exist as a dimer mimicking DNA and to bind to host 21 restriction enzymes, thus preventing the degradation of the viral genome by the host. 22 Here we report that Ocr can also inhibit host transcription by directly binding to 23 bacterial RNA polymerase (RNAP) and competing with the recruitment of RNAP by 24 sigma factors. Using cryo electron microscopy, we determined the structures of Ocr 25 bound to RNAP.
    [Show full text]
  • Regulation of Host Tyrosine Kinases by the Escherichia Coli and Salmonella
    Regulation of host tyrosine kinases by the Escherichia coli and Salmonella ADP-ribosyltransferases EspJ, SeoC and SboC Ph.D. Thesis Dominic James Pollard Imperial College London Department of Life Sciences Centre for Molecular Bacteriology and Infection Supervisor – Prof. Gad Frankel This thesis is presented for the degree of Doctor of Philosophy of Imperial College London and Diploma of Imperial College London 2018 1 Candidate’s declaration I, Dominic Pollard, declare that this thesis constitutes my own work and that any external contributions are appropriately acknowledged or referenced from hereon in. Copyright declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work. 2 Abstract The human pathogens enteropathogenic and enterohaemorrhagic E. coli (EPEC and EHEC) and Salmonella enterica are responsible for a significant proportion of the global diarrhoeal disease burden. EPEC, EHEC and the mouse-restricted pathogen C. rodentium (CR) make up the attaching and effacing (A/E) pathogens. CR is used to model EPEC/EHEC pathogenesis in vivo, where it colonises the apical surface of mouse intestinal mucosae, destroying microvilli and inducing colonic crypt hyperplasia (CCH) and diarrhoeal disease symptoms. The type three secretion system (T3SS) is instrumental to the infectivity of the A/E pathogens, as well as Salmonella, through the injection of sets of effector proteins into the host cell cytosol for the manipulation of host cell signalling.
    [Show full text]
  • Perspectives
    Copyright Ó 2006 by the Genetics Society of America Perspectives Anecdotal, Historical and Critical Commentaries on Genetics Edited by James F. Crow and William F. Dove Chaos and Order in Spontaneous Mutation John W. Drake1 Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709-2233 HIS story starts with one of those unanticipated vided by the NDV protocols. I quickly found that phages T turning points that mark the lives of most of us. produced interesting results at least an order of magni- Around 1960 I was working at the University of Illinois at tude more frequently than did NDV. Urbana using Newcastle disease virus (NDV), a tractable Phages and antimutators: There followed a burst of animal virus that infects chickens rather than humans. investigations into the mutation process in phage T4. A (Working previously with polioviruses, I had acquired key component of these investigations was reversion extraordinarily high serum titers against all three strains.) analysis of rII mutations, which tended to reveal that The NDV plaque assay required that chicken embryos of the mutants I was making—not only with UV, but also the correct age be harvested and dissociated into single arising spontaneously in free phages and induced by cells, which were then used to produce monolayers photosensitizers—contained several different kinds of that became confluent in a few days. Virus samples were mutations. Here, however, a barrier arose. Transitions adsorbed to the monolayers, which were then incubated of both types could be recognized, as well as many frame- for a few more days while plaques formed.
    [Show full text]
  • Physiological Role of the Short Form of the Histidine Protein Kinase, Cheas, in Bacterial Chemotaxis
    Loyola University Chicago Loyola eCommons Dissertations Theses and Dissertations 1997 Physiological Role of the Short Form of the Histidine Protein Kinase, Cheas, in Bacterial Chemotaxis Barry Patrick McNamara Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_diss Part of the Microbiology Commons Recommended Citation McNamara, Barry Patrick, "Physiological Role of the Short Form of the Histidine Protein Kinase, Cheas, in Bacterial Chemotaxis" (1997). Dissertations. 3422. https://ecommons.luc.edu/luc_diss/3422 This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 1997 Barry Patrick McNamara LOYOLA UNIVERSITY CHICAGO PHYSIOLOGICAL ROLE OF THE SHORT FORM OF THE HISTIDINE PROTEIN KINASE, CheA8 , IN BACTERIAL CHEMOTAXIS A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL IN CANDIDACY FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY BY BARRY PATRICK MCNAMARA CHICAGO, ILLINOIS MAY 1997 Copyright by Barry P. McNamara, 1997 All rights reserved. ii ACKNOWLEDGMENTS The culmination of this work would not have been possible were it not for the encouragement and generous support provided to me by my parents Justina and Eugene McNamara during the course of all my studies. I also wish to recognize my immediate co-workers, with whom I have had the honor and privilege of working with for the past several years.
    [Show full text]